Characterization of the peptide-binding specificity of HLA-B*7301

Tissue Antigens

Volumn 47, Issue 6, 1996, Pages 472-477

  Barber, L D ^a   Percival, L ^a   Parham, P ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ankylosing spondylitis; Endogenous peptide; HLA B*7301; ME1 monoclonal antibody; Peptide binding specificity

Indexed keywords

GLYCOPROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS;

BINDING SITES; CELL LINE, TRANSFORMED; HLA-B ANTIGENS; HUMANS; PEPTIDES;

EID: 0029974649     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02588.x     Document Type: Article

References (38)

1. Parham P, Adams EJ, Arnett KL. The origins of HLA-A, B, C polymorphism. Immunol Rev 1995: 143: 141-180.
2. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. W15.1: allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tswi K, Aizawa M, Sasusuki T, ed. HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford Science Publications, Oxford University Press, 1992: 1065-1220.
3. Parham P, Arnett KL, Adams EJ et al. The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens 1994: 43: 302-313.
4. Vilches C, de Pablo R, Herrero MJ, Moreno ME, Kreisler M. HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27. Immunogenetics 1994: 40: 166.
5. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, Parham P. Overlap in the repertoires of peptides bound in vivo by a group of related HLA-B allotypes. Curr Biol 1995: 5: 179-190.
6. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 1982: 5: 49-59.
7. Parham P, Antonelli P, Herzenberg LA, Kipps TJ, Fuller A, Ward FE. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum Immunol 1986: 15: 44-67.
8. Little A-M, Domena JD, Hildebrand WH et al. HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope. Tissue Antigens 1994: 43: 38-43.
9. Hanes J, Klaudiny J, von der Kammer H, Scheit KH. Characterization by cDNA cloning of the mRNA of human ribosomal protein L8. Biochem Biophys Res Commun 1993: 197: 1223-1228.
10. Michiels L, Van der Rauwelaert E, Van Hasselt F, Kas K, Merregaert J. Fau cDNA encodes a ubiquitin like-S30 fusion protein and is expressed as an antisense sequence in the Finkel-Biskis-Reilly murine sarcoma virus. Oncogene 1993: 8: 2537-2546.
11. Barber LD, Parham P. Peptide binding by major histocompatibility complex molecules. Annu Rev Cell Bio 1993 9: 163-206.
12. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6Å resolution. J Mol Biol 1991: 219: 277-319.
13. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991: 353: 326-329.
14. Rötzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee H-G. Dominant aromatic/aliphatic C terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 1994: 39: 74-77.
15. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992: 70: 1035-1048.
16. Buxton SE, Benjamin RJ, Clayberger C, Parham P, Krensky AM. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27. J Exp Med 1992: 175: 809-820.
17. Falk K, Rötzschke O, Takiguchi M et al. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 1995: 41: 162-164.
18. Engelhard VH. Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 1994: 6: 13-23.
19. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995: 41: 178-228.
20. Falk K, Rötzschke O. Consensus motifs and peptide ligands of MHC class I molecules. Semin Immunol 1993: 5: 81-94.
21. Driscoll J, Brown MG, Finley D, Monaco JJ. MHC linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993: 365: 262-264.
22. Gaczynska M, Rock KL, Goldberg AL. γ interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993: 365: 264-267.
23. Heemels M-T, Schumacher TNM, Wonigeit K, Ploegh HL. Peptide translocation by variants of the transporter associated with antigen processing. Science 1993: 262: 2059-2063.
24. Neefjes JJ, Momburg F, Hämmerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993: 261: 769-771.
25. Shepherd JC, Schumacher TNM, Ashton-Rickardt PG et al. TAP-dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell 1993: 74: 577-584.
26. Momburg F, Roelse J, Howard JC, Butcher GW, Hämmerling GJ, Neefjes JJ. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994: 367: 648-651.
27. Androlewicz MJ, Cresswell P. Human transporters associated with antigen processing possess a promiscuous peptide binding site. Immunity 1994: 1: 7-14.
28. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 1986: 234: 179-186.
29. Mentlein R. Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett 1988: 234: 251-256.
30. Niedermann G, Butz S, Ihlenfeldt HG et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995: 2: 289-299.
31. McMichael A, Bell J. HLA-B27: a disease associated immune response gene. Res Immunol 1991: 142: 475-482.
32. Benjamin R, Parham P. Guilty by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990: 11: 137-142.
33. Tanigaki N, Fruci D, Vigneti E et al. The peptide binding specificity of HLA-B27 subtypes. Immunogenetics 1994: 40: 192-198.
34. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1991: 337: 640-642.
35. López-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995: 45: 169-176.
36. Kapasi K, Inman RD. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. J Immunol 1994: 153: 833-840.
37. Huczko EL, Bodnar WM, Benjamin D et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 1993: 151: 2572-2587.
38. Sidney J, del Guercio M-F, Southwood S et al. Several HLA alleles share overlapping peptide specificities. J Immunol 1995: 154: 247-259.